China Post-marketing Surveillance (PMS) Study of Aldurazyme®

Clinical trial NCT05134571 · COMPLETED

Trial details

NCT number: NCT05134571
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Mucopolysaccharidosis I

Start date: 2021-10-28
Primary completion: 2023-07-26
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.